Honeywell Aerospace is the subject of a class action lawsuit alleging it made false and misleading statements about supplier impacts, supply constraints, and a government cybersecurity investigation. The lawsuit follows Honeywell's announcement of a 70% net income drop and a significant cut in 2026 earnings guidance, which caused the stock to fall over 23%. Additionally, a $2 million settlement with the U.S. Department of Justice over cybersecurity compliance issues further pressured the stock. Investors who bought Honeywell stock between June and September 2026 have until November 23, 2026, to seek lead plaintiff status in the case.
Honeywell Aerospace is the subject of a class action lawsuit amid recent financial and legal challenges. For readers following the Industrials sector, here is Pluang's market snapshot as of Sep 24, 2026 03:43 WIB: out of 92 priced US Industrials stocks, 37 rose and 55 fell. Among notable movers, LUNR dropped 5.91% to USD 15.28 with a typical hold time of 1 day and 85% buy orders, while RDW fell 4.25% to USD 11.26 with a longer hold time of 16 days and 60% sell orders. SPCX declined 4.11% to USD 148.36, held typically for 37 days, with 58% sell orders.
NeoVolta reported a weak Q4 with revenue dropping to $13,460 and a loss of $0.24 per share, missing analyst expectations. Despite this, full-year revenue rose 58% to $13.3 million as the company expanded beyond residential markets. The Q4 loss widene...
BlackBerry is expected to report Q3 earnings with an EPS of $0.04 and revenue around $143.55 million, in line with company guidance. The company has a strong track record of beating earnings estimates, driven by growth in its QNX automotive software ...
On September 23, Jaguar Health's stock plunged about 74%, reversing a prior gain, without any confirmed negative news. Alkami Technology's shares fell 19% after ending a strategic review and deciding to remain independent. Other stocks like Cullinan ...
Wheeler REIT (WHLR) surged 190.91% after a 1-for-9 reverse stock split, though no new catalyst was confirmed. Artelo Biosciences (ARTL) rose 74% following a provisional patent application for its obesity drug candidate ART27.13, based on early mouse ...
In the week of September 14-20, 2026, Solana's decentralized exchanges (DEXs) recorded about 208 million spot trades, exceeding the New York Stock Exchange's (NYSE) 189-190 million trades. This marks the first time a blockchain-based exchange has ove...
